Search
ARANESP 150 µg, Solution injectable
Details
| --- | Description |
|---|---|
| Pack | Boîte de 4 seringues |
| Strength (Dosage) | 150 µg |
| Laboratory | FRESENUIS MÉDICAL |
| Ingredients | Darbepoeitin Alfa |
| Therapeutic class | Antianémique |
| ATC code | B03XA02 |
| PPH | $923.00 |
| PPV | $940.70 |
| Refundable | Yes |
| Refund base | $940.70 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Traitement de l’anémie symptomatique liée à l’insuffisance rénale chronique (IRC) chez l’adulte et l’enfant. Traitement de l’anémie symptomatique chez des patients adultes atteints de pathologies malignes non myéloïdes et recevant une chimiothérapie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem